社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
magiczhou
IP属地：海外
+关注
帖子 · 14
帖子 · 14
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
magiczhou
magiczhou
·
2021-09-03
抖音的点cai的很准啊
非常抱歉，此主贴已删除
看
4,082
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-09-01
期待啊
Apple Car车身外部或配备显示屏，向周围车辆预警
告知周围的司机和行人Apple Car正在或者将要做什么。
Apple Car车身外部或配备显示屏，向周围车辆预警
看
3,710
回复
评论
点赞
1
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-09-01
超预期了
中国生物制药：上半年净利润84.8亿元，同比增长583.6%
8月31日，中国生物制药公告，上半年营收143.5亿元，同比增长13.5%；净利润84.8亿元，同比增长583.6%。集团在制药业务方面继续以发展专科治疗领域相关产品为主，致力打造专科品牌。集团的主要治疗领域包括抗肿瘤用药、肝病用药、心脑血管用药、骨科用药、呼吸系统用药、肠外营养用药及其他产品。
中国生物制药：上半年净利润84.8亿元，同比增长583.6%
看
4,595
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-09-01
今天不会又高开低走吧
中国生物制药半年报：营收净利双创新高 主业及疫苗强势拉动
8月31日，中国生物制药发布中期业绩。财报显示，中国生物制药上半年实现营业收入143.54亿元，创下历史新高，实现归母净利润84.8亿元，同比大幅增长583.6%，扣除以投资科兴获得的巨额回报为主的联...
中国生物制药半年报：营收净利双创新高 主业及疫苗强势拉动
看
3,708
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-29
安卓与苹果系统的差距已经不大
非常抱歉，此主贴已删除
看
4,822
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-26
京东不是拼多多等能比的，继续看好
非常抱歉，此主贴已删除
看
5,078
回复
1
点赞
3
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-25
疫情还在持续，疫苗股值得期待
非常抱歉，此主贴已删除
看
4,586
回复
评论
点赞
1
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-21
百度靠AI和智能驾驶能翻身吗，现在价位可以搏一搏了
非常抱歉，此主贴已删除
看
4,588
回复
评论
点赞
1
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-17
我的计划是买入港股科技股，抄底哔哩哔哩，腾讯，京东，美团，小米
🔥【8月16日】看本周关键事件，聊今日交易计划
@Buy_Sell：
聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 8月16日，港股三大指数低开，恒指跌0.1%报26365点，国指跌0.03%9374点报，恒生科技指数跌0.41%6562点报。 盘面上，生物医药股强势，$丽珠医药(01513)$ 高开逾3%，$金斯瑞生物科技(01548)$ 涨超3%；银行股、电力股、物管股、物管股、建材水泥股、保险股、银行股普遍上涨，$招商银行(03968)$ 涨2%；大型科技股普跌，$哔哩哔哩-SW(09626)$ 跌逾4%，$百度集团-SW(09888)$ 低开逾3%，美团、京东、$腾讯控股(00700)$ 均跌超1%；教育股继续下跌，汽车股、濠赌股普跌。$万科企业(02202)$ 海外涨8.66%，此前发布盈利预告，预计上半年净利润录得上升不少于390%。
🔥【8月16日】看本周关键事件，聊今日交易计划
看
1.21万
回复
5
点赞
7
编组 21备份 2
分享
举报
magiczhou
magiczhou
·
2021-08-16
股价能涨吗
顺丰国际与有赞AllValue合作签约 助力国货 畅销全球
【深圳商报讯】（记者 肖晗）记者从顺丰获悉，顺丰国际与有赞AllValue于近日达成官方合作，顺丰国际成为AllValue平台官方指定物流合作伙伴，并携手共同赋能有赞AllValue平台商家，助力国货 ...
顺丰国际与有赞AllValue合作签约 助力国货 畅销全球
看
6,136
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4090283997865460","uuid":"4090283997865460","gmtCreate":1627202062504,"gmtModify":1628666306121,"name":"magiczhou","pinyin":"magiczhou","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":88,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.11","exceedPercentage":"60.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":812784318,"gmtCreate":1630625523234,"gmtModify":1630625523234,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"抖音的点cai的很准啊","listText":"抖音的点cai的很准啊","text":"抖音的点cai的很准啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812784318","repostId":"1196494670","repostType":2,"isVote":1,"tweetType":1,"viewCount":4082,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":818704257,"gmtCreate":1630446791479,"gmtModify":1630446791479,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"期待啊","listText":"期待啊","text":"期待啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818704257","repostId":"1144404853","repostType":2,"repost":{"id":"1144404853","kind":"news","pubTimestamp":1630418779,"share":"https://www.laohunote.com/m/news/1144404853?lang=zh_CN&edition=full","pubTime":"2021-08-31 22:06","market":"us","language":"zh","title":"Apple Car车身外部或配备显示屏，向周围车辆预警","url":"https://stock-news.laohu8.com/highlight/detail?id=1144404853","media":"新浪科技","summary":"告知周围的司机和行人Apple Car正在或者将要做什么。","content":"<p>北京时间8月31日晚间消息，据报道，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>公司今日获得的一项技术专利显示，苹果正在研发的电动汽车Apple Car，其车身外部可能配备LED屏幕，以告知周围的司机和行人Apple Car正在或者将要做什么。</p>\n<p>鉴于苹果多年来一直在公共道路上进行测试，传闻已久的苹果汽车Apple Car预计将包括某种形式的自动驾驶技术。虽然苹果在测试自动驾驶技术时，似乎集中在识别道路和对条件做出反应上，但还必须能够处理一些其他驾驶功能。</p>\n<p>其中一个问题是，向其他司机指示车辆下一步要做什么。当前，要想知道前方车辆将要去到那里，可以通过前方司机的侧影（大体轮廓）或其他较小的驾驶行为来获得一丝线索。但如果前方车辆是一辆自动驾驶汽车，可能就不会以同样的方法来获取线索。</p>\n<p>而今日，苹果从美国专利商标局（PTO）获得一项新的专利授权。这项专利名为“外部照明与警告系统”，苹果在该专利描述中称，自动驾驶系统可以向道路上的其他用户提供更明确的信息。苹果相信，可以使用更复杂的照明系统来完成同样的工作，而不是通常所使用的简单的指示灯。</p>\n<p>简而言之，苹果的这系统包括放置在车辆上和车身周围的显示屏，可能是一条“包罗万象”的LED灯带。这个长长的显示屏，可以向道路上的其他人显示各种信息，不仅仅是刹车已经启动，或者他们希望向左或向右行驶。</p>\n<p>还可能包括更详细的刹车信息，汽车与后面另一辆车的相对速度，下一步动作的倒计时计时器，以及其他信息。它们可以是文本，也可以由图形和视频组成。对于正在停车的司机，显示屏可以显示告别信息；或者司机从远处走来，显示屏可以欢迎用户进入车辆。</p>\n<p>去年12月有报道称，苹果正在推进自动驾驶汽车技术，目标是最早在2024年生产一款可能包括自家突破性电池技术的乘用车。而知名苹果分析师郭明錤认为，苹果的电动汽车最早也要等到2025年才会发布。</p>\n<p>诺贝尔化学奖获得者、“锂电池之父”吉野彰（Akira Yoshino）上周在接受采访时表示，苹果要想在2025年之前推出Apple Car电动汽车，今年年底之前就要发布一些相关内容了。</p>","source":"sina_tech","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Car车身外部或配备显示屏，向周围车辆预警</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Car车身外部或配备显示屏，向周围车辆预警\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 22:06 北京时间 <a href=https://finance.sina.com.cn/tech/2021-08-31/doc-iktzscyx1525852.shtml><strong>新浪科技</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间8月31日晚间消息，据报道，苹果公司今日获得的一项技术专利显示，苹果正在研发的电动汽车Apple Car，其车身外部可能配备LED屏幕，以告知周围的司机和行人Apple Car正在或者将要做什么。\n鉴于苹果多年来一直在公共道路上进行测试，传闻已久的苹果汽车Apple Car预计将包括某种形式的自动驾驶技术。虽然苹果在测试自动驾驶技术时，似乎集中在识别道路和对条件做出反应上，但还必须能够处理...</p>\n\n<a href=\"https://finance.sina.com.cn/tech/2021-08-31/doc-iktzscyx1525852.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/a05bbd5986633bd2074fc78fe1d2f246","relate_stocks":{"AAPL":"苹果"},"source_url":"https://finance.sina.com.cn/tech/2021-08-31/doc-iktzscyx1525852.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144404853","content_text":"北京时间8月31日晚间消息，据报道，苹果公司今日获得的一项技术专利显示，苹果正在研发的电动汽车Apple Car，其车身外部可能配备LED屏幕，以告知周围的司机和行人Apple Car正在或者将要做什么。\n鉴于苹果多年来一直在公共道路上进行测试，传闻已久的苹果汽车Apple Car预计将包括某种形式的自动驾驶技术。虽然苹果在测试自动驾驶技术时，似乎集中在识别道路和对条件做出反应上，但还必须能够处理一些其他驾驶功能。\n其中一个问题是，向其他司机指示车辆下一步要做什么。当前，要想知道前方车辆将要去到那里，可以通过前方司机的侧影（大体轮廓）或其他较小的驾驶行为来获得一丝线索。但如果前方车辆是一辆自动驾驶汽车，可能就不会以同样的方法来获取线索。\n而今日，苹果从美国专利商标局（PTO）获得一项新的专利授权。这项专利名为“外部照明与警告系统”，苹果在该专利描述中称，自动驾驶系统可以向道路上的其他用户提供更明确的信息。苹果相信，可以使用更复杂的照明系统来完成同样的工作，而不是通常所使用的简单的指示灯。\n简而言之，苹果的这系统包括放置在车辆上和车身周围的显示屏，可能是一条“包罗万象”的LED灯带。这个长长的显示屏，可以向道路上的其他人显示各种信息，不仅仅是刹车已经启动，或者他们希望向左或向右行驶。\n还可能包括更详细的刹车信息，汽车与后面另一辆车的相对速度，下一步动作的倒计时计时器，以及其他信息。它们可以是文本，也可以由图形和视频组成。对于正在停车的司机，显示屏可以显示告别信息；或者司机从远处走来，显示屏可以欢迎用户进入车辆。\n去年12月有报道称，苹果正在推进自动驾驶汽车技术，目标是最早在2024年生产一款可能包括自家突破性电池技术的乘用车。而知名苹果分析师郭明錤认为，苹果的电动汽车最早也要等到2025年才会发布。\n诺贝尔化学奖获得者、“锂电池之父”吉野彰（Akira Yoshino）上周在接受采访时表示，苹果要想在2025年之前推出Apple Car电动汽车，今年年底之前就要发布一些相关内容了。","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":818704885,"gmtCreate":1630446764647,"gmtModify":1630446764647,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"超预期了","listText":"超预期了","text":"超预期了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818704885","repostId":"2163853122","repostType":2,"repost":{"id":"2163853122","kind":"news","pubTimestamp":1630399200,"share":"https://www.laohunote.com/m/news/2163853122?lang=zh_CN&edition=full","pubTime":"2021-08-31 16:40","market":"hk","language":"zh","title":"中国生物制药：上半年净利润84.8亿元，同比增长583.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2163853122","media":"界面","summary":"8月31日，中国生物制药公告，上半年营收143.5亿元，同比增长13.5%；净利润84.8亿元，同比增长583.6%。集团在制药业务方面继续以发展专科治疗领域相关产品为主，致力打造专科品牌。集团的主要治疗领域包括抗肿瘤用药、肝病用药、心脑血管用药、骨科用药、呼吸系统用药、肠外营养用药及其他产品。","content":"<div>\n<p>8月31日，中国生物制药公告，上半年营收143.5亿元，同比增长13.5%；净利润84.8亿元，同比增长583.6%。集团在制药业务方面继续以发展专科治疗领域相关产品为主，致力打造专科品牌。集团的主要治疗领域包括抗肿瘤用药、肝病用药、心脑血管用药、骨科用药、呼吸系统用药、肠外营养用药及其他产品。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021083116401977563386&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国生物制药：上半年净利润84.8亿元，同比增长583.6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国生物制药：上半年净利润84.8亿元，同比增长583.6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 16:40 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021083116401977563386&s=b><strong>界面</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月31日，中国生物制药公告，上半年营收143.5亿元，同比增长13.5%；净利润84.8亿元，同比增长583.6%。集团在制药业务方面继续以发展专科治疗领域相关产品为主，致力打造专科品牌。集团的主要治疗领域包括抗肿瘤用药、肝病用药、心脑血管用药、骨科用药、呼吸系统用药、肠外营养用药及其他产品。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021083116401977563386&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","relate_stocks":{"01177":"中国生物制药"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021083116401977563386&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2163853122","content_text":"8月31日，中国生物制药公告，上半年营收143.5亿元，同比增长13.5%；净利润84.8亿元，同比增长583.6%。集团在制药业务方面继续以发展专科治疗领域相关产品为主，致力打造专科品牌。集团的主要治疗领域包括抗肿瘤用药、肝病用药、心脑血管用药、骨科用药、呼吸系统用药、肠外营养用药及其他产品。","news_type":1,"symbols_score_info":{"01177":1}},"isVote":1,"tweetType":1,"viewCount":4595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":818704162,"gmtCreate":1630446709656,"gmtModify":1630446709656,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"今天不会又高开低走吧","listText":"今天不会又高开低走吧","text":"今天不会又高开低走吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818704162","repostId":"2163579468","repostType":2,"repost":{"id":"2163579468","kind":"news","pubTimestamp":1630414980,"share":"https://www.laohunote.com/m/news/2163579468?lang=zh_CN&edition=full","pubTime":"2021-08-31 21:03","market":"hk","language":"zh","title":"中国生物制药半年报：营收净利双创新高 主业及疫苗强势拉动","url":"https://stock-news.laohu8.com/highlight/detail?id=2163579468","media":"证券日报网","summary":"8月31日，中国生物制药发布中期业绩。财报显示，中国生物制药上半年实现营业收入143.54亿元，创下历史新高，实现归母净利润84.8亿元，同比大幅增长583.6%，扣除以投资科兴获得的巨额回报为主的联...","content":"<div>\n<p>8月31日，中国生物制药发布中期业绩。财报显示，中国生物制药上半年实现营业收入143.54亿元，创下历史新高，实现归母净利润84.8亿元，同比大幅增长583.6%，扣除以投资科兴获得的巨额回报为主的联营公司及合营公司盈利，归母净利润仍同比增22.9%。亮眼业绩的驱动力在于公司多年高研发的投入，上半年研发总开支约人民币18.8亿元，同比上升15%，占总收入的13.1%。\n 近年来，中生制药的研发...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202108312074579362.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国生物制药半年报：营收净利双创新高 主业及疫苗强势拉动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国生物制药半年报：营收净利双创新高 主业及疫苗强势拉动\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 21:03 北京时间 <a href=http://finance.eastmoney.com/a/202108312074579362.html><strong>证券日报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月31日，中国生物制药发布中期业绩。财报显示，中国生物制药上半年实现营业收入143.54亿元，创下历史新高，实现归母净利润84.8亿元，同比大幅增长583.6%，扣除以投资科兴获得的巨额回报为主的联营公司及合营公司盈利，归母净利润仍同比增22.9%。亮眼业绩的驱动力在于公司多年高研发的投入，上半年研发总开支约人民币18.8亿元，同比上升15%，占总收入的13.1%。\n 近年来，中生制药的研发...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202108312074579362.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"01177":"中国生物制药"},"source_url":"http://finance.eastmoney.com/a/202108312074579362.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163579468","content_text":"8月31日，中国生物制药发布中期业绩。财报显示，中国生物制药上半年实现营业收入143.54亿元，创下历史新高，实现归母净利润84.8亿元，同比大幅增长583.6%，扣除以投资科兴获得的巨额回报为主的联营公司及合营公司盈利，归母净利润仍同比增22.9%。亮眼业绩的驱动力在于公司多年高研发的投入，上半年研发总开支约人民币18.8亿元，同比上升15%，占总收入的13.1%。\n 近年来，中生制药的研发投入持续加码，进入临床阶段的项目中，有50%为自主研发品种。2018年以后上市的60余个新产品对销售增长的贡献率超过80%，所占销售收入的份额已经超过40%并仍在快速增长。\n “今年公司业绩全面反弹，来自集采的压力和疫情的负面影响已经成为历史。”中国生物制药董事会主席谢其润在当日的业绩会上指出，今年对于中生制药而言，有着承上启下的意义，亮眼的业绩是过往经营的结果，也是下一段征途的起点。公司计划三年内上市新品种近百个，覆盖多个治疗领域。\n 分疾病领域来看，上半年中生制药在抗肿瘤、肠外营养、心脑血管、呼吸、骨科5大核心领域均保持双位数高增长。抗肿瘤药成为公司第一大业务板块，上半年实现收入50亿元，同比增长25%，收入占比持续提升，已达35%。除安罗替尼外，近年来陆续获批的众多新品种也加速了该板块的增长，其中7个品种增速超过50%。\n 就在8月5日，中生制药肿瘤免疫创新药物派安普利单抗注射液(商品名：安尼可)正式获得国家药品监督管理局的批准，成为完善公司抗肿瘤管线的一块关键“拼图”。临床研究数据显示，在当前上市的国产PD-1药物中，派安普利有着明显的安全和差异化优势，主要研究终点客观缓解率(ORR)高达89.4%。\n 心脑血管药物收入为15亿元，同比提升45%，占比10%，同比提升两个百分点，主要得益于国家集采以及新品的高速放量。骨科板块收入为12.5亿元，增长20%，占比为9%，核心增长动力主要来自公司制定的慢病管理策略，有效地提高了患者的用药依从性，从而拉动成熟品种的再次增长。肠外营养板块收入为6亿元，增长39%，该板块本季度贡献了两大收入过亿的品种。\n 谢其润认为，近期出台的行业新政，表明国家大力推动促进创新药自主研发的主旋律没变，长远来看对致力创新研发的中生制药是利好消息。从业务管线来看，集采、医保谈判和业务转型给中生制药带来的阵痛期已过，创新药的增速完全可以弥补仿制药的萎缩，而进入集采医药后的销售放量使得主力产品对收入贡献不断提升。未来，集团将借助X-LAB和全球创新枢纽网络布局，聚焦FIC预期销售峰值不小于5亿美元的品种。 （文章来源：证券日报网）","news_type":1,"symbols_score_info":{"01177":1}},"isVote":1,"tweetType":1,"viewCount":3708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":813827274,"gmtCreate":1630189764298,"gmtModify":1704956748147,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"安卓与苹果系统的差距已经不大","listText":"安卓与苹果系统的差距已经不大","text":"安卓与苹果系统的差距已经不大","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/813827274","repostId":"2163076062","repostType":2,"isVote":1,"tweetType":1,"viewCount":4822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837723238,"gmtCreate":1629930133824,"gmtModify":1629930133824,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"京东不是拼多多等能比的，继续看好","listText":"京东不是拼多多等能比的，继续看好","text":"京东不是拼多多等能比的，继续看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837723238","repostId":"1109644839","repostType":4,"isVote":1,"tweetType":1,"viewCount":5078,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":837381916,"gmtCreate":1629857305135,"gmtModify":1629857305135,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"疫情还在持续，疫苗股值得期待","listText":"疫情还在持续，疫苗股值得期待","text":"疫情还在持续，疫苗股值得期待","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837381916","repostId":"2162082184","repostType":4,"isVote":1,"tweetType":1,"viewCount":4586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":836734509,"gmtCreate":1629522227201,"gmtModify":1629522227201,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"百度靠AI和智能驾驶能翻身吗，现在价位可以搏一搏了","listText":"百度靠AI和智能驾驶能翻身吗，现在价位可以搏一搏了","text":"百度靠AI和智能驾驶能翻身吗，现在价位可以搏一搏了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/836734509","repostId":"1168385577","repostType":2,"isVote":1,"tweetType":1,"viewCount":4588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":839872659,"gmtCreate":1629153986771,"gmtModify":1629153986771,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"我的计划是买入港股科技股，抄底哔哩哔哩，腾讯，京东，美团，小米","listText":"我的计划是买入港股科技股，抄底哔哩哔哩，腾讯，京东，美团，小米","text":"我的计划是买入港股科技股，抄底哔哩哔哩，腾讯，京东，美团，小米","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":5,"repostSize":1,"link":"https://laohu8.com/post/839872659","repostId":"830561020","repostType":1,"repost":{"id":830561020,"gmtCreate":1629081935856,"gmtModify":1629082420973,"author":{"id":"3527667596890271","authorId":"3527667596890271","name":"Buy_Sell","avatar":"https://static.tigerbbs.com/a5f0ed79a338c758a22e0b4ea13bf9d2","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667596890271","authorIdStr":"3527667596890271"},"themes":[],"title":"🔥【8月16日】看本周关键事件，聊今日交易计划","htmlText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 8月16日，港股三大指数低开，恒指跌0.1%报26365点，国指跌0.03%9374点报，恒生科技指数跌0.41%6562点报。 盘面上，生物医药股强势，<a target=\"_blank\" href=\"https://laohu8.com/S/01513\">$丽珠医药(01513)$</a> 高开逾3%，<a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a> 涨超3%；银行股、电力股、物管股、物管股、建材水泥股、保险股、银行股普遍上涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03968\">$招商银行(03968)$</a> 涨2%；大型科技股普跌，<a target=\"_blank\" href=\"https://laohu8.com/S/09626\">$哔哩哔哩-SW(09626)$</a> 跌逾4%，<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 低开逾3%，美团、京东、<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 均跌超1%；教育股继续下跌，汽车股、濠赌股普跌。<a target=\"_blank\" href=\"https://laohu8.com/S/02202\">$万科企业(02202)$</a> 海外涨8.66%，此前发布盈利预告，预计上半年净利润录得上升不少于390%。","listText":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 8月16日，港股三大指数低开，恒指跌0.1%报26365点，国指跌0.03%9374点报，恒生科技指数跌0.41%6562点报。 盘面上，生物医药股强势，<a target=\"_blank\" href=\"https://laohu8.com/S/01513\">$丽珠医药(01513)$</a> 高开逾3%，<a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a> 涨超3%；银行股、电力股、物管股、物管股、建材水泥股、保险股、银行股普遍上涨，<a target=\"_blank\" href=\"https://laohu8.com/S/03968\">$招商银行(03968)$</a> 涨2%；大型科技股普跌，<a target=\"_blank\" href=\"https://laohu8.com/S/09626\">$哔哩哔哩-SW(09626)$</a> 跌逾4%，<a target=\"_blank\" href=\"https://laohu8.com/S/09888\">$百度集团-SW(09888)$</a> 低开逾3%，美团、京东、<a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> 均跌超1%；教育股继续下跌，汽车股、濠赌股普跌。<a target=\"_blank\" href=\"https://laohu8.com/S/02202\">$万科企业(02202)$</a> 海外涨8.66%，此前发布盈利预告，预计上半年净利润录得上升不少于390%。","text":"聊聊今日份的交易想法，包括对于大盘走势后续的看法？看涨/看跌哪只股票、晒晒单等等。 港股市场 8月16日，港股三大指数低开，恒指跌0.1%报26365点，国指跌0.03%9374点报，恒生科技指数跌0.41%6562点报。 盘面上，生物医药股强势，$丽珠医药(01513)$ 高开逾3%，$金斯瑞生物科技(01548)$ 涨超3%；银行股、电力股、物管股、物管股、建材水泥股、保险股、银行股普遍上涨，$招商银行(03968)$ 涨2%；大型科技股普跌，$哔哩哔哩-SW(09626)$ 跌逾4%，$百度集团-SW(09888)$ 低开逾3%，美团、京东、$腾讯控股(00700)$ 均跌超1%；教育股继续下跌，汽车股、濠赌股普跌。$万科企业(02202)$ 海外涨8.66%，此前发布盈利预告，预计上半年净利润录得上升不少于390%。","images":[{"img":"https://static.tigerbbs.com/8c224c9889536a14f83eca563ae0bb07","width":"666","height":"284"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830561020","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":12064,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":830217754,"gmtCreate":1629075579478,"gmtModify":1629075579478,"author":{"id":"4090283997865460","authorId":"4090283997865460","name":"magiczhou","avatar":"https://static.tigerbbs.com/01fdc42eed602d0584b36043c5177036","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090283997865460","authorIdStr":"4090283997865460"},"themes":[],"title":"","htmlText":"股价能涨吗","listText":"股价能涨吗","text":"股价能涨吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830217754","repostId":"2159035248","repostType":2,"repost":{"id":"2159035248","kind":"news","pubTimestamp":1629068144,"share":"https://www.laohunote.com/m/news/2159035248?lang=zh_CN&edition=full","pubTime":"2021-08-16 06:55","market":"sh","language":"zh","title":"顺丰国际与有赞AllValue合作签约 助力国货 畅销全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2159035248","media":"深圳商报","summary":"【深圳商报讯】（记者 肖晗）记者从顺丰获悉，顺丰国际与有赞AllValue于近日达成官方合作，顺丰国际成为AllValue平台官方指定物流合作伙伴，并携手共同赋能有赞AllValue平台商家，助力国货 ...","content":"<div>\n<p>【深圳商报讯】（记者 肖晗）记者从顺丰获悉，顺丰国际与有赞AllValue于近日达成官方合作，顺丰国际成为AllValue平台官方指定物流合作伙伴，并携手共同赋能有赞AllValue平台商家，助力国货畅销全球。 目前，双方已完成系统对接，针对跨境电商卖家需求，量身定制优质高效、经济实惠的跨境电商物流解决方案。 即日起，有赞AllValue商家在跨境物流配送选项中，可在线选择顺丰国际电商专递服务...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20210816/c631849870.shtml\">网页链接</a>\n\n</div>\n","source":"tonghuashun","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>顺丰国际与有赞AllValue合作签约 助力国货 畅销全球</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n顺丰国际与有赞AllValue合作签约 助力国货 畅销全球\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-16 06:55 北京时间 <a href=http://stock.10jqka.com.cn/hks/20210816/c631849870.shtml><strong>深圳商报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【深圳商报讯】（记者 肖晗）记者从顺丰获悉，顺丰国际与有赞AllValue于近日达成官方合作，顺丰国际成为AllValue平台官方指定物流合作伙伴，并携手共同赋能有赞AllValue平台商家，助力国货畅销全球。 目前，双方已完成系统对接，针对跨境电商卖家需求，量身定制优质高效、经济实惠的跨境电商物流解决方案。 即日起，有赞AllValue商家在跨境物流配送选项中，可在线选择顺丰国际电商专递服务...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20210816/c631849870.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/a7123c00c718afd2209048e9d94f04a1","relate_stocks":{"002352":"顺丰控股"},"source_url":"http://stock.10jqka.com.cn/hks/20210816/c631849870.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","article_id":"2159035248","content_text":"【深圳商报讯】（记者 肖晗）记者从顺丰获悉，顺丰国际与有赞AllValue于近日达成官方合作，顺丰国际成为AllValue平台官方指定物流合作伙伴，并携手共同赋能有赞AllValue平台商家，助力国货畅销全球。 目前，双方已完成系统对接，针对跨境电商卖家需求，量身定制优质高效、经济实惠的跨境电商物流解决方案。 即日起，有赞AllValue商家在跨境物流配送选项中，可在线选择顺丰国际电商专递服务。同时，顺丰国际将为有赞AllValue的商家提供物流费用优惠，近期还将上线国际特惠等物流产品。 据悉，顺丰国际电商业务目前已覆盖全球225个国家及地区，国际快递业务覆盖78个国家及地区。顺丰国际与有赞AllValue的深度合作，可从物流端助力平台卖家优化运营成本、提升商品流转时效，提升中国商家的竞争优势。 接下来，双方还将携手进一步探索更多的市场合作，联合推出更多优质的跨境电商物流解决方案，帮助中国商家在国际市场加速成长。 作者：肖晗\n关注同花顺财经（ths518），获取更多机会\n\n责任编辑：jdm","news_type":1,"symbols_score_info":{"002352":1}},"isVote":1,"tweetType":1,"viewCount":6136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}